Manjari Valluri

Manjari Valluri, MD, MPH has a diverse and extensive work experience in the medical field. Manjari currently serves as the Medical Director at Novavax Inc since March 2022. Prior to that, they worked as a Consultant Physician in Pharmacovigilance at Regeneron Pharmaceuticals from January 2020 to February 2022. From July 2017 to January 2020, they served as a Pharmacovigilance Physician at Covance. Manjari also held positions at Global Pharma Tek as the Associate Vice President of Pharmacovigilance and Regulatory Strategy from January 2016 to July 2017, and at Boehringer Ingelheim as a Pharmacovigilance Physician and Medical Director from June 2016 to February 2017. Manjari worked as a Consultant Medical Monitor and Pharmacovigilance Physician at Ludwig Cancer Research from March 2015 to July 2016. Prior to that, they served as a Medical Director for Drug Safety and Clinical Development at FibroGen Inc from June 2014 to December 2014. From December 2009 to June 2014, they worked at Pfizer as a Medical Director specializing in Oncology PSSR, and also served as a Pharmacovigilance Physician from December 2009 to October 2010. Manjari has also worked at sanofi-aventis as a Pharmacovigilance specialist from October 2008 to December 2009, and at Bristol Myers Squibb as a CSM from 2005 until 2008.

Manjari Valluri, MD, MPH completed their Master's in Public Health (MPH) in Epidemiology and Biostatistics from UNSW in 2002. Manjari also holds a degree in Medicine (MBBS) from medical jobs updates. Prior to their medical degree, they attended Hindu Senior Secondary School. In addition to their formal education, they have obtained certifications in "Communicating about Culturally Sensitive Issues" and "Confronting Bias: Thriving Across Our Differences" from LinkedIn in 2020.